ABT

101.88

2.03% -2.11

Pre-mercato: 102.46 0.58 +0.57%

Abbott Laboratories (ABT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$103.99

Aprire:

$104.76

Volume 24 ore:

10.06M

Relative Volume:

0.94

Capitalizzazione di mercato:

$177.03B

Reddito:

$44.33B

Utile/perdita netta:

$6.50B

Rapporto P/E:

27.41

EPS:

3.717

Flusso di cassa netto:

$7.40B

1 W Prestazione:

-2.83%

1M Prestazione:

-12.44%

6M Prestazione:

-23.46%

1 anno Prestazione:

-22.12%

Intervallo 1D:

$101.82

$104.77

Intervallo di 1 settimana:

$101.82

$105.98

Portata 52W:

$101.82

$139.06

Abbott Laboratories Stock (ABT) Company Profile

Nome

Abbott Laboratories

Settore

Healthcare (1115)

Industria

Medical Devices (143)

Telefono

(224) 667-6100

Indirizzo

100 ABBOTT PARK ROAD, ABBOTT PARK, IL

Dipendente

115,000

Cinguettio

@AbbottNews

Prossima data di guadagno

2026-04-16

Ultimi documenti SEC

ABT's Discussions on Twitter

Compare ABT vs SYK, MDT, BSX, EW

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ABT Abbott Laboratories	101.88	177.03B	44.33B	6.50B	7.40B	3.717
SYK Stryker Corp	326.10	124.89B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	85.74	110.08B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	62.93	93.53B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	79.50	45.84B	6.07B	1.06B	1.34B	1.8063

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-10-10	Iniziato	The Benchmark Company	Buy
2025-07-18	Aggiornamento	Jefferies	Hold → Buy
2025-06-16	Iniziato	Leerink Partners	Market Perform
2024-10-08	Iniziato	Oppenheimer	Outperform
2024-09-19	Iniziato	Piper Sandler	Overweight
2024-07-30	Downgrade	Edward Jones	Buy → Hold
2024-05-30	Iniziato	Goldman	Buy
2023-07-21	Aggiornamento	Wolfe Research	Underperform → Peer Perform
2023-05-30	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2023-04-20	Reiterato	Barclays	Overweight
2023-04-20	Reiterato	Bernstein	Outperform
2023-04-20	Reiterato	JP Morgan	Overweight
2023-04-20	Reiterato	Raymond James	Outperform
2023-04-20	Reiterato	UBS	Buy
2023-04-20	Reiterato	Wolfe Research	Underperform
2023-03-29	Iniziato	UBS	Buy
2022-10-26	Iniziato	Mizuho	Neutral
2022-10-18	Iniziato	Barclays	Overweight
2022-10-12	Iniziato	Jefferies	Hold
2022-07-06	Iniziato	Wolfe Research	Underperform
2022-03-02	Ripresa	BofA Securities	Buy
2022-01-27	Reiterato	Credit Suisse	Outperform
2022-01-27	Reiterato	Morgan Stanley	Overweight
2022-01-27	Reiterato	Raymond James	Outperform
2022-01-27	Reiterato	UBS	Buy
2021-12-10	Iniziato	RBC Capital Mkts	Outperform
2021-10-27	Aggiornamento	Atlantic Equities	Neutral → Overweight
2021-10-14	Iniziato	Redburn	Neutral
2021-05-25	Iniziato	Barclays	Overweight
2021-04-15	Iniziato	Atlantic Equities	Neutral
2021-01-28	Aggiornamento	BTIG Research	Neutral → Buy
2020-09-11	Iniziato	Wolfe Research	Outperform
2020-06-01	Downgrade	Goldman	Neutral → Sell
2020-03-05	Iniziato	Citigroup	Buy
2020-02-13	Iniziato	Goldman	Neutral
2020-02-06	Ripresa	BTIG Research	Neutral
2020-01-02	Downgrade	Guggenheim	Buy → Neutral
2019-06-13	Reiterato	BofA/Merrill	Buy
2019-02-07	Reiterato	BofA/Merrill	Buy
2019-01-02	Downgrade	Citigroup	Neutral → Sell
2018-11-30	Aggiornamento	Goldman	Neutral → Buy
2018-10-16	Iniziato	Barclays	Overweight
2018-06-27	Iniziato	Bernstein	Outperform
2018-01-30	Reiterato	Citigroup	Neutral
2018-01-25	Reiterato	Stifel	Buy
2018-01-25	Aggiornamento	William Blair	Mkt Perform → Outperform
2018-01-03	Iniziato	Evercore ISI	Outperform
2018-01-02	Aggiornamento	JP Morgan	Neutral → Overweight
2018-01-02	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2017-10-19	Reiterato	RBC Capital Mkts	Outperform
2017-10-19	Reiterato	Stifel	Buy

Mostra tutto

Abbott Laboratories Borsa (ABT) Ultime notizie

Mar 30, 2026

Abbott (ABT) Enhances Cancer Care with OncoEMR Test Integration - GuruFocus

Mar 30, 2026

Abbott (ABT) Dips More Than Broader Market: What You Should Know - Yahoo Finance Australia

Mar 30, 2026

Dairy industry consolidation | Lactalis, Abbott Complete Major NZ Dairy Deals - en.edairynews.com

Mar 30, 2026

SCHD ETF Rebalance Adds Abbott, UnitedHealth as Dividend Fund Inflows Hit 4-Year High - TechStock²

Mar 30, 2026

Abbott, Flatiron Health Integrate Precision Oncology Tests Into Oncology EMR Platform - Clinical Lab Products

Mar 30, 2026

Abbott Laboratories stock hits 52-week low at 102.39 USD - Investing.com

Mar 30, 2026

Abbott Laboratories stock hits 52-week low at 102.39 USD By Investing.com - Investing.com Australia

Mar 30, 2026

Abbott integrates cancer tests into Flatiron’s EMR platform By Investing.com - Investing.com India

Mar 30, 2026

Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform - marketscreener.com

Mar 30, 2026

4,700 cancer providers can now order Abbott tests in their records system - Stock Titan

Mar 30, 2026

This Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks - The Motley Fool

Mar 30, 2026

Mar 29, 2026

Inside the high-stakes business battle over feeding preterm babies - USA Today

Mar 29, 2026

Is Abbott Laboratories (ABT) Offering Value After Recent Share Price Weakness? - simplywall.st

Mar 29, 2026

Chesley Taft & Associates LLC Has $30.29 Million Stock Holdings in Abbott Laboratories $ABT - MarketBeat

Mar 29, 2026

Mar 28, 2026

Net Worth Advisory Group Acquires Shares of 10,905 Abbott Laboratories $ABT - MarketBeat

Mar 28, 2026

Mar 27, 2026

Abbott subsidiary dodges whistleblower claim from fired remote worker - hcamag.com

Mar 27, 2026

Abbott Culture Alignment Supports Long Term Execution And Valuation Story - simplywall.st

Mar 27, 2026